Premium
P4–278: Clinical gamma‐secretase inhibitors (GSIs) alter beta‐amyloid 40/42 ratio in brain and show CSF beta‐amyloid rebound in vivo
Author(s) -
Nolan Charles,
Atchison Kevin,
Pustilnik Leslie,
Noell Stephen,
Robshaw Ashley,
Ambroise Claude,
Gonzales Cathleen,
Oborski Christine,
HajosKorcsok Eva,
Lu Yasong,
Zhang Liming,
Efremov Ivan,
Brodney Michael,
Subramanyam Chakrapani,
Stepan Antonia,
Riddell David
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1671
Subject(s) - in vivo , genetically modified mouse , beta (programming language) , medicine , chemistry , amyloid beta , endocrinology , pharmacology , transgene , biology , biochemistry , disease , gene , microbiology and biotechnology , computer science , programming language